Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/9926
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPatel, Khushboo-
dc.date.accessioned2021-08-10T10:16:51Z-
dc.date.available2021-08-10T10:16:51Z-
dc.date.issued2021-05-
dc.identifier.urihttp://10.1.7.192:80/jspui/handle/123456789/9926-
dc.publisherInstitute of Pharmacy, Nirma University, A'baden_US
dc.relation.ispartofseriesPDR00682;-
dc.subjectDissertation Reporten_US
dc.subjectPharmaceutical Analysisen_US
dc.subjectRegulatory Affairsen_US
dc.subject19MPHen_US
dc.subject19MPH813en_US
dc.subjectPDR00682en_US
dc.titlePreparation of Modul3-IIIContent for Sirolimus Polymeric Nanoparticles' (ANDA Product RAPCIN 1MG) Approval Process in USA and INDIAen_US
dc.typeDissertationen_US
Appears in Collections:M.Pharm. Research Reports, Pharmaceutical Analysis

Files in This Item:
File Description SizeFormat 
PDR00682_19MPH813.pdfPDR006824.69 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.